IL13RA1 and Alzheimer disease: MicroRNA-143 emerges as a pivotal regulator in the context of AD, primarily due to its ability to target the IL-13 receptor alpha 1 (IL-13Ra1) and its potential to mitigate the symptoms of this allergic skin disorder [33].